Ad
Monday, 2 September 2019
China expands drug bulk-buy program, puts pressure on pharma firms
China has expanded a pilot drug bulk-buying program to almost the entire country in an attempt to negotiate lower prices from drug manufacturers, heaping fresh pressure on multinational pharmaceutical companies and their domestic rivals.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment